StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.82+0.02 (+0.10%)

Close on Nov 18, 2026Market cap $936.43MP/E –Yield –

Silence Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Silence Therapeutics's price to book ratio was 24.3× on Nov 11, 2026, against 4.3× a year earlier. Over the last 5 years it ranged from 1.0× to 45.9×, with a median of 13.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202624.3×+20.4
2025Dec 31, 20253.9×−8.5
2024Dec 31, 202412.4×−10.5
2023Dec 29, 202322.9×−13.6
2022Dec 30, 202236.5×–

More Silence Therapeutics figures

See a number that looks wrong?